BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14693257)

  • 1. Distance traveled to outpatient drug treatment and client retention.
    Beardsley K; Wish ED; Fitzelle DB; O'Grady K; Arria AM
    J Subst Abuse Treat; 2003 Dec; 25(4):279-85. PubMed ID: 14693257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation and retention in drug abuse treatment services research.
    Vaughn T; Sarrazin MV; Saleh SS; Huber DL; Hall JA
    J Subst Abuse Treat; 2002 Dec; 23(4):387-97. PubMed ID: 12495801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy.
    King AC; Canada SA
    J Subst Abuse Treat; 2004 Apr; 26(3):189-95. PubMed ID: 15063912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of distance on utilization of outpatient mental health aftercare following inpatient substance abuse treatment.
    Schmitt SK; Phibbs CS; Piette JD
    Addict Behav; 2003 Aug; 28(6):1183-92. PubMed ID: 12834661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. City's racial composition shapes treatment center characteristics and services.
    VĂ©lez MB; Campos-Holland AL; Arndt S
    J Ethn Subst Abuse; 2008; 7(2):188-99. PubMed ID: 19042805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Travel distance to outpatient substance use disorder treatment facilities for Spanish-speaking clients.
    Guerrero EG; Kao D; Perron BE
    Int J Drug Policy; 2013 Jan; 24(1):38-45. PubMed ID: 22705358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accessibility and utilization patterns of a mobile medical clinic among vulnerable populations.
    Gibson BA; Ghosh D; Morano JP; Altice FL
    Health Place; 2014 Jul; 28():153-66. PubMed ID: 24853039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the early therapeutic alliance in predicting drug treatment dropout.
    Meier PS; Donmall MC; McElduff P; Barrowclough C; Heller RF
    Drug Alcohol Depend; 2006 Jun; 83(1):57-64. PubMed ID: 16298088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does travel distance influence length of stay in elective colorectal surgery?
    Jackson KL; Glasgow RE; Hill BR; Mone MC; Sklow B; Scaife CL; Sheng X; Peche WJ
    Dis Colon Rectum; 2013 Mar; 56(3):367-73. PubMed ID: 23392153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs.
    Broome KM; Flynn PM; Simpson DD
    Health Serv Res; 1999 Aug; 34(3):791-806. PubMed ID: 10445903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of residential treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; MacMaster SA; Seiters J
    J Psychoactive Drugs; 2013; 45(2):122-31. PubMed ID: 23909000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention of homeless clients in substance abuse treatment. Findings from the National Institute on Alcohol Abuse and Alcoholism Cooperative Agreement Program.
    Orwin RG; Garrison-Mogren R; Jacobs ML; Sonnefeld LJ
    J Subst Abuse Treat; 1999; 17(1-2):45-66. PubMed ID: 10435252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
    Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
    Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention, early dropout and treatment completion among therapeutic community admissions.
    Darke S; Campbell G; Popple G
    Drug Alcohol Rev; 2012 Jan; 31(1):64-71. PubMed ID: 21426420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone dosage and retention: an examination of the 60 mg/day threshold.
    Brady TM; Salvucci S; Sverdlov LS; Male A; Kyeyune H; Sikali E; DeSale S; Yu P
    J Addict Dis; 2005; 24(3):23-47. PubMed ID: 16186081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programme factors that influence completion of residential treatment.
    Meier PS; Best D
    Drug Alcohol Rev; 2006 Jul; 25(4):349-55. PubMed ID: 16854661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting drop out from, and retention in, specialist drug treatment services: a case control study in the North West of England.
    Beynon CM; McMinn AM; Marr AJ
    BMC Public Health; 2008 May; 8():149. PubMed ID: 18460202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abortion services in rural Washington State, 1983-1984 to 1993-1994: availability and outcomes.
    Dobie SA; Hart LG; Glusker A; Madigan D; Larson EH; Rosenblatt RA
    Fam Plann Perspect; 1999; 31(5):241-5. PubMed ID: 10723649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do drug treatment facilities increase clients' exposure to potential neighborhood-level triggers for relapse? A small-area assessment of a large, public treatment system.
    Jacobson JO
    J Urban Health; 2006 Mar; 83(2):150-61. PubMed ID: 16736365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.